Showing results (1271-1280 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|September 8, 2018
Late stent thrombosis in a patient with CYP2C19*3/*17 genotype and clopidogrel high on-treatment platelet reactivityShirley Siang Ning Tan, Keng Tat Koh, Lee Len Tiong, et al.
Pharmacogenomics|September 8, 2018
Genetic risk factors for VIPN in childhood acute lymphoblastic leukemia patients identified using whole-exome sequencingRachid Abaji, Francesco Ceppi, Swati Patel, et al.
Pharmacogenomics|September 11, 2018
Does cardiology hold pharmacogenetics to an inconsistent standard? A comparison of evidence among recommendationsJasmine A Luzum, Jason C Cheung
Pharmacogenomics|September 11, 2018
Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patientsSarah Sim, Jonas Bergh, Mats Hellström, et al.
Pharmacogenomics|December 19, 2009
ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han ChineseJin Zhu, Weijuan Zhang, Yanyan Li, et al.
Pharmacogenomics|June 14, 2019
Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozoleJacqueline M Dempsey, Kelley M Kidwell, Christina L Gersch, et al.
Pharmacogenomics|June 14, 2019
High levels of several antipsychotics and antidepressants due to a pharmacogenetic cause: a case reportPaola Mian, Metten Somers, Maarten Ten Berg, et al.
Pharmacogenomics|June 29, 2019
The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevirZifang Guo, Luzelena Caro, Michael N Robertson, et al.
Pharmacogenomics|June 29, 2019
The ANKS1B gene and its associated phenotypes: focus on CNS drug responseRabha M Younis, Rachel M Taylor, Patrick M Beardsley, et al.
Pharmacogenomics|June 29, 2019
Impact of genetic polymorphisms on opioid misuse: a scoping reviewSanjida Ahmed, Zia Choudhry, Junaid A Bhatti
Pageof 276